https://www.marketscreener.com/quote/stock/23ANDME-HOLDING-CO-115575622/news/23andMe-announces-further-expansion-of-23ME-00610-Phase-1-2a-clinical-trial-in-advanced-neuroendocri-45599277/?utm_source=telegram&utm_medium=social&utm_campaign=share